Category Archives: Healthcare

Abeona Therapeutics (ABEO) Has a New Rating from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright initiated coverage with a Buy rating on Abeona Therapeutics (ABEO – Research Report) and a price target of $11.00. The company’s shares closed last Monday at $2.54, close to its

Spero Therapeutics (SPRO) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Spero Therapeutics (SPRO – Research Report) today and set a price target of $35.00. The company’s shares closed last Monday at $8.89, close to its 52-week low of $7.99. According

Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (NASDAQ: AXSM) and Baudax Bio (NASDAQ: BXRX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Axsome Therapeutics (AXSM – Research Report) and Baudax Bio (BXRX – Research Report) with bullish sentiments. Axsome Therapeutics (AXSM) In a report

Biomerica (BMRA) Receives a Buy from B.Riley FBR

In a report released today, Andrew D’silva from B.Riley FBR maintained a Buy rating on Biomerica (BMRA – Research Report), with a price target of $6.25. The company’s shares closed last Monday at $2.97. According to TipRanks.com, D’silva is a

Selecta Biosciences (SELB) Initiated with a Buy at William Blair

Selecta Biosciences (SELB – Research Report) received a Buy rating from William Blair analyst Raju Prasad today. The company’s shares closed last Monday at $3.32, close to its 52-week high of $3.50. According to TipRanks.com, Prasad is a 5-star analyst

Xeris Pharmaceuticals (XERS) Gets a Buy Rating from Mizuho Securities

Mizuho Securities analyst Difei Yang maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research Report) today and set a price target of $22.00. The company’s shares closed last Monday at $6.19, close to its 52-week low of $5.30. According